Drawing for GLAAS

USPTO serial 86403659

GLAAS

Reviewed by CopyMark Law Group

Reg. 5069193Status 710
Filing date
Status date
Registration date
Oct 25, 2016
Examiner
GUTTADAURO, JULIE MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with GLAAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer M. Lantz

JENNIFER M. LANTZ Haynes and Boone LLP2323 Victory Avenue, Suite 700Dallas, TX 75219UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of immunological diseases and disorders; pharmaceutical preparation and substances for the treatment of infectious diseases; pharmaceutical preparations and substances for the treatment of allergies; pharmaceutical preparations for use as immune system modulatorsSECTION 8 - CANCELLEDJan 27, 2014
042Pharmaceutical and biotechnology analysis and research; scientific research in the fields of biotechnology, immunology and pharmacology; research and development of new pharmaceutical products for others; medical and scientific research in the field of oncology and immunologySECTION 8 - CANCELLEDJan 27, 2014

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 5, 2023C8..CANCELLED SEC. 8 (6-YR)—
Oct 25, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 25, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 17, 2016SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 16, 2016CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 16, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 16, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 17, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 16, 2016EX2GSOU EXTENSION 2 GRANTED—
May 12, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 13, 2016IUAFUSE AMENDMENT FILED—
Apr 13, 2016EXT2SOU EXTENSION 2 FILED—
Apr 13, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 13, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 13, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 13, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 13, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 13, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 7, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 5, 2015EX1GSOU EXTENSION 1 GRANTED—
Oct 5, 2015EXT1SOU EXTENSION 1 FILED—
Oct 5, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 5, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 14, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 17, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 17, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 28, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 10, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 10, 2015DOCKASSIGNED TO EXAMINER—
Oct 1, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 26, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance